Showing results (231-240 of 242) with videos related to
Sort By:
Pageof 25
Genome Biology|November 27, 2019
DNA methylation aging clocks: challenges and recommendationsChristopher G Bell, Robert Lowe, Peter D Adams, et al.Science Translational Medicine|March 28, 2014
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancerThushangi N Pathiraja, Shweta R Nayak, Yuanxin Xi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 8, 2024
A Multicenter Open-Label Randomized Phase II Study of Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor-Naïve EGFR-Mutant Metastatic Non-Small Cell Lung Cancer (RAMOSE trial)Xiuning Le, Jyoti D Patel, Elaine Shum, et al.Blood Advances|June 5, 2023
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized studyPierre Fenaux, Marco Gobbi, Patricia L Kropf, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018Gregory P Kalemkerian, Billy W Loo, Wallace Akerley, et al.Biorxiv : the Preprint Server for Biology|November 28, 2024
Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDSH Josh Jang, Guillermo Urrutia, Andreas Due Orskov, et al.Cancer Discovery|April 27, 2013
Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic driversCurtis R Pickering, Jiexin Zhang, Suk Young Yoo, et al.Blood Neoplasia|June 17, 2026
Bone marrow immunosuppressive states associate with survival after guadecitabine and atezolizumab therapy in HMA-R/R MDSH Josh Jang, Guillermo Urrutia, Andreas Due Ørskov, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2023
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor TherapyH Josh Jang, Galen Hostetter, Alexander W Macfarlane, et al.Nature Communications|January 30, 2021
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomasXin Hu, Marcos R Estecio, Runzhe Chen, et al.Pageof 25